Skip to main navigation Skip to search Skip to main content

The landscape of viral associations in human cancers

  • PCAWG Pathogens
  • , PCAWG Consortium
  • German Cancer Research Center
  • Ontario Institute for Cancer Research
  • University of East Anglia
  • The Earlham Institute
  • Heinrich Pette Institute - Leibniz Institute for Experimental Virology
  • Partner Site Hamburg-Borstel-Lübeck-Riems
  • University of Hamburg
  • University College London
  • The Francis Crick Institute
  • University of Zurich
  • The Institute of Cancer Research
  • Heidelberg University 
  • Berlin Institute of Health and Charitè - Universitätsmedizin Berlin
  • University of Montreal
  • RIKEN
  • University of Alabama at Birmingham
  • HudsonAlpha Institute for Biotechnology
  • Broad Institute
  • Harvard University
  • Dana-Farber Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • University of Helsinki
  • Wellcome Trust Genome Campus
  • Memorial Sloan-Kettering Cancer Center
  • The University of Tokyo
  • The University of Chicago
  • Keimyung University
  • Gachon University
  • Hiroshima University
  • King Faisal Specialist Hospital and Research Centre
  • Spanish National Cancer Research Centre (CNIO)
  • National Institutes of Health
  • University of California at San Diego
  • Provincial Health Services Authority
  • University of Melbourne

Research output: Contribution to journalArticlepeer-review

324 Scopus citations

Abstract

Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, for which whole-genome and—for a subset—whole-transcriptome sequencing data from 2,658 cancers across 38 tumor types was aggregated, we systematically investigated potential viral pathogens using a consensus approach that integrated three independent pipelines. Viruses were detected in 382 genome and 68 transcriptome datasets. We found a high prevalence of known tumor-associated viruses such as Epstein–Barr virus (EBV), hepatitis B virus (HBV) and human papilloma virus (HPV; for example, HPV16 or HPV18). The study revealed significant exclusivity of HPV and driver mutations in head-and-neck cancer and the association of HPV with APOBEC mutational signatures, which suggests that impaired antiviral defense is a driving force in cervical, bladder and head-and-neck carcinoma. For HBV, HPV16, HPV18 and adeno-associated virus-2 (AAV2), viral integration was associated with local variations in genomic copy numbers. Integrations at the TERT promoter were associated with high telomerase expression evidently activating this tumor-driving process. High levels of endogenous retrovirus (ERV1) expression were linked to a worse survival outcome in patients with kidney cancer.

Original languageEnglish
Pages (from-to)320-330
Number of pages11
JournalNature Genetics
Volume52
Issue number3
DOIs
StatePublished - 1 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The landscape of viral associations in human cancers'. Together they form a unique fingerprint.

Cite this